Publications by authors named "Sally Stone"

Claim this Profile
A
A multicenter randomized, double-blind, placebo-controlled, parallel-group study to evaluate the effects of a 1-year regimen of orally inhaled fluticasone furoate 50 µg once daily on growth velocity in prepubertal, pediatric participants with well-controlled asthma.
Philippe Bareille, Varsha Imber, Jodie Crawford, Bernadetta Majorek-Olechowska, Zeina Karam-Absi, Sally Stone

Pediatr Pulmonol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of a single ascending subcutaneous dose of GSK3772847 in healthy participants.
Eleni Pefani, Sally Stone, Chang-Qing Zhu, Carol Nunn, David Fairman

Pharmacol Res Perspect· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial.
Courtney Crim, Sally Stone, Valerie Millar, Sally Lettis, Elisabeth H Bel

J Allergy Clin Immunol Glob· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Knemometry Assessment of Short-term Growth in Children with Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Cross-over Trial" Clin Ther 2017;39:1191-1199.
Ole D Wolthers, Sally Stone, Philippe Bareille, Susan Tomkins, Sanjeev Khindri

Clin Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial.
Ole D Wolthers, Sally Stone, Philippe Bareille, Susan Tomkins, Sanjeev Khindri

Clin Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist.
Jiangtao Lin, Huaping Tang, Ping Chen, Haoyan Wang, Mi-Kyeong Kim, Sally Stone

Allergy Asthma Proc· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
Jiangtao Lin, Jian Kang, Sang Haak Lee, Changzheng Wang, Xiangdong Zhou, Sally Stone

Respir Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.
Ashley Woodcock, Jan Lötvall, William W Busse, Eric D Bateman, Sally Stone

BMC Pulm Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.
Jan Lötvall, Eugene R Bleecker, William W Busse, Paul M O'Byrne, Ashley Woodcock, Sally Stone

Respir Med· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids.
Jan Lötvall, Eric D Bateman, Eugene R Bleecker, William W Busse, Ashley Woodcock, Sally Stone

Eur Respir J· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis